04:22
2026-09-28
cryptobriefing.com
artificial-intelligence
Nabla Bio expects human trials of AI-designed antibody drugs within two years
Nabla Bio, an OpenAI-backed Massachusetts biotech company, said its JAM-2 model generated high-affinity antibody candidates against 26 targets and that it expects first-in-human trials of AI-designed …